VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151,447 | -48.1% | 15,391 | +33.3% | 0.00% | – |
| Q2 2023 | $291,843 | +7.5% | 11,549 | +13.4% | 0.00% | – |
| Q4 2022 | $271,377 | -11.9% | 10,183 | -0.9% | 0.00% | – |
| Q3 2022 | $308,000 | +41.9% | 10,273 | +26.2% | 0.00% | – |
| Q2 2022 | $217,000 | -97.6% | 8,141 | -96.0% | 0.00% | -100.0% |
| Q3 2021 | $8,934,000 | +12138.4% | 205,896 | +12516.2% | 0.00% | – |
| Q1 2021 | $73,000 | -71.3% | 1,632 | -81.9% | 0.00% | – |
| Q4 2020 | $254,000 | +109.9% | 9,014 | +209.4% | 0.00% | – |
| Q3 2020 | $121,000 | -34.2% | 2,913 | -25.0% | 0.00% | – |
| Q2 2020 | $184,000 | +1433.3% | 3,886 | +886.3% | 0.00% | – |
| Q1 2020 | $12,000 | +9.1% | 394 | -56.5% | 0.00% | – |
| Q4 2019 | $11,000 | – | 905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |